Published : 30 July, 2024
Dr. Ullas Batra, Co-Director of Medical Oncology and Chief of Thoracic Medical Oncology at Rajiv Gandhi Cancer Institute, commends the Union Budget 2024 for its support of cancer care. He particularly applauds the customs duty exemptions on cancer medicines, which will make essential drugs more affordable for patients. Dr. Batra sees this move as a strategic effort to boost domestic production and improve healthcare accessibility. This initiative is a significant step towards advancing healthcare infrastructure and reducing treatment costs. By lowering drug prices, the customs duty exemptions are expected to benefit cancer patients, particularly those who otherwise could not afford such crucial medications.
RGCIRC, Niti Bagh
